Breaking Down China Baoan Group Co., Ltd. Financial Health: Key Insights for Investors

Curious whether China Baoan Group Co., Ltd. (000009.SZ) is a recovery story or a cautionary tale? Recent data paint a complex picture: the company sits at a market cap of 26.54 billion CNY with a share price of 10.29 CNY (Dec 12, 2025) after reporting Q3 2025 revenue of 5.97 billion CNY - a 29.68% sequential jump - while TTM revenue is 22.41 billion CNY (+7.59% YoY) despite a steep 34.12% annual drop from 30.71 billion CNY in 2023 to 20.23 billion CNY in 2024; profitability remains thin with TTM net income of 70.48 million CNY (EPS 0.03 CNY) even as Q1 2025 net income surged 138% and operating margin improved from -0.8% to -0.4% (non‑GAAP margin 0.2%), the company paid a final cash dividend of 0.30 CNY per ten A shares in August 2025, and operational metrics show revenue per employee ≈1.35 million CNY across 16,658 staff; balance‑sheet risks are real-Shanshan Co., Ltd. reported total liabilities of 23.673 billion CNY in 2024 with interest‑bearing debt at 67.29% and a short‑term debt gap of 5.355 billion CNY that triggered bankruptcy restructuring in Feb 2025, prompting China Baoan to lead a restructuring consortium to stabilize Shanshan while pursuing growth initiatives including a 500 million CNY green‑technology investment, a push to raise international sales to 30% of revenue by 2025 (international sales were 3 billion CNY in 2023), and talent investments of 200 million CNY to boost retention-additionally, Gortune Investment held a 16.02% stake as of 2024, and the group's equity structure spans listed subsidiaries such as BTR New Materials and Mayinglong Pharmaceutical, factors investors will want to weigh as they read on.

China Baoan Group Co., Ltd. (000009.SZ) - Revenue Analysis

Q3 2025 revenue performance and trailing figures show a mixed recovery trend for China Baoan Group Co., Ltd. with sequential acceleration but a still-contracted base relative to 2023.

• Q3 2025 revenue: 5.97 billion CNY - up 29.68% quarter-on-quarter.
• Trailing twelve months (TTM) revenue: 22.41 billion CNY - up 7.59% year-on-year.
• 2024 annual revenue: 20.23 billion CNY - a 34.12% decline from 30.71 billion CNY in 2023.
• Revenue per employee: ~1.35 million CNY with total employees: 16,658.
• Price-to-sales (P/S) ratio: 1.18.
• Market capitalization: 26.54 billion CNY; share price: 10.29 CNY (as of December 12, 2025).

Key revenue implications for investors:

• The strong Q3 2025 sequential lift (29.68%) indicates operational re-acceleration after a large 2024 base decline.
• TTM growth of 7.59% signals partial year recovery but remains well below 2023 peak revenue of 30.71 billion CNY.
• Revenue per employee (~1.35M CNY) can be compared with peers to assess productivity and capital allocation efficiency.
• At a P/S of 1.18 and market cap of 26.54 billion CNY, the market prices roughly 1.18x annual sales - useful for relative valuation against sector norms.

Further company context and business model detail: China Baoan Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

China Baoan Group Co., Ltd. (000009.SZ) - Profitability Metrics

• Trailing twelve months (TTM) net income: 70.48 million CNY
• TTM earnings per share (EPS): 0.03 CNY
• Final cash dividend declared for 2024: 0.30 CNY per ten A shares (payable August 27, 2025)
• Dividend history: consistent payer, most recent distribution in August 2025

• Q1 2025 profit rebound (+138%) despite a modest revenue contraction (-3%) suggests improved cost control or one-off items affecting bottom line.
• Operating margin remains slightly negative on GAAP basis (-0.4%) but non-GAAP margin turned mildly positive (0.2%), indicating adjustments that materially affect operating profitability.
• Dividend policy remains shareholder-friendly with a cash payout for 2024 and distributions continuing into August 2025.

China Baoan Group Co., Ltd. (000009.SZ) - Debt vs. Equity Structure

• Group-level profitability: net loss attributable to shareholders improved to a loss of ¥185.2 million in 2024 (vs. a loss of ¥278.4 million in 2023), reflecting narrower losses but continued negative EPS pressure.
• Subsidiary leverage: Shanshan Co., Ltd. (a China Baoan subsidiary) reported total liabilities of ¥23.673 billion at end-2024, with interest-bearing liabilities comprising 67.29% of that total.
• Short-term liquidity stress: Shanshan's short-term debt gap was ¥5.355 billion, precipitating a funding crisis and leading to bankruptcy restructuring initiated in February 2025.
• Rescue/restructuring: China Baoan is leading a consortium to invest in and restructure Shanshan Group to address the debt gap and stabilize operations.
• Equity holdings: China Baoan's equity base includes multiple listed subsidiaries (e.g., BTR New Materials Group Co., Ltd.; Mayinglong Pharmaceutical Group Co., Ltd.), providing asset-side value and potential recovery sources.
• Shareholder concentration: Gortune Investment is the second-largest shareholder with a 16.02% stake as of 2024.

• Investor considerations: debt-heavy subsidiaries (notably Shanshan) create contingent liabilities and refinancing risk at the group level; listed equity stakes offer recovery optionality but realization depends on restructuring outcomes.
• Operational/financial remedy path being pursued: consortium-led capital injection and formal bankruptcy restructuring for Shanshan, with China Baoan in a leading role to protect group interests.
• For further context on corporate direction and stated long-term priorities, see: Mission Statement, Vision, & Core Values (2026) of China Baoan Group Co., Ltd.

China Baoan Group Co., Ltd. (000009.SZ) - Liquidity and Solvency

• Dividend policy: final cash dividend of 0.30 CNY per ten A shares declared for 2024, payable on August 27, 2025; most recent dividend paid August 2025.
• Profitability shift: Q1 2025 net income rose 138% year-over-year despite a 3% decline in revenue vs Q1 2024.
• Margins: GAAP operating margin improved from -0.8% (Q1 2024) to -0.4% (Q1 2025); non-GAAP operating margin moderated from 0.4% (Q1 2024) to 0.2% (Q1 2025).
• Trailing twelve months (TTM) net income: 70.48 million CNY; EPS (TTM): 0.03 CNY.

• Liquidity considerations: dividend payout in Aug 2025 signals available distributable cash, but negative GAAP operating margins indicate operating cash generation remains constrained and sensitivity to working capital and financing costs is elevated.
• Solvency considerations: modest net income (70.48M CNY TTM) and low EPS (0.03 CNY) mean limited internal buffer; leverage ratios and cash reserves should be monitored closely by investors (see company filings for debt schedule and cash balances).

China Baoan Group Co., Ltd. (000009.SZ) - Valuation Analysis

• Market valuation vs. sales: Price-to-Sales (P/S) = 1.18 - the market values the company at just above one year of sales, signaling a modest revenue-based valuation compared with peers in construction/real estate-related sectors.
• Market capitalization and price: Market cap = 26.54 billion CNY; share price = 10.29 CNY (as of 12-Dec-2025).
• Profitability and EPS: Trailing twelve months (TTM) net income = 70.48 million CNY; EPS (TTM) = 0.03 CNY.
• Dividend distribution: Final cash dividend for 2024 = 0.30 CNY per ten A shares (payable 27-Aug-2025), equivalent to 0.03 CNY per A share.
• Recent quarter dynamics (Q1 2025): Net income rose 138% YoY despite revenue declining 3% YoY; operating margin improved to -0.4% from -0.8% in Q1 2024.

• Valuation context: A P/S of 1.18 places the stock in a low-to-moderate revenue multiple territory - attractive if margins recover and earnings continue to rebound.
• Profit vs. market cap: TTM net income of 70.48 million CNY is small relative to a 26.54 billion CNY market cap, implying low current return on market value and highlighting sensitivity to earnings volatility.
• Dividend signal: The declared 2024 final cash dividend (0.03 CNY per share equivalent) provides a modest yield and signals management willingness to return cash despite slim profitability.
• Quarterly trajectory: Q1 2025's 138% net income surge and improved operating margin (from -0.8% to -0.4%) suggest operational stabilization, even with slight revenue contraction; investors should watch sustainability of margin improvement and revenue drivers.

China Baoan Group Co., Ltd. (000009.SZ) - Risk Factors

• Restructuring exposure: China Baoan is leading a restructuring consortium to inject capital into Shanshan Group (a subsidiary) to resolve its severe debt pressure and stabilize operations.
• Subsidiary leverage: Shanshan Co., Ltd.'s total liabilities reached 23.673 billion CNY by end-2024; interest-bearing liabilities account for 67.29% of that figure, amplifying refinancing risk.
• Short-term liquidity shortfall: Shanshan recorded a short-term debt gap of 5.355 billion CNY, precipitating a funding crisis and resulting in bankruptcy restructuring in February 2025.
• Concentrated ownership risk: Gortune Investment holds a 16.02% stake in China Baoan (second-largest shareholder as of 2024), which can influence strategic decisions and restructuring outcomes.
• Dividend signaling but timing risk: The company has a history of paying dividends (most recently in August 2025), yet future payouts depend on successful resolution of the Shanshan restructuring and broader cash-flow recovery.
• Operational/earnings volatility: Q1 2025 reported a net income surge of 138% YoY despite a 3% decline in revenue versus Q1 2024 - indicating profit-margin or one-off item sensitivity that investors should scrutinize.

• Balance-sheet contagion: China Baoan's capital commitment to Shanshan could increase consolidated leverage, impair credit profiles, and constrain capital allocation for other operations.
• Refinancing & interest-rate risk: With 67.29% of Shanshan's liabilities interest-bearing, rising rates or tighter credit conditions would raise interest expenses and refinancing costs across the group.
• Execution & integration risk: Successful restructuring depends on creditor negotiations, asset valuations, and consortium coordination; failure could lead to further value erosion.
• Market & earnings quality risk: The 138% net-income surge in Q1 2025, despite lower revenue, warrants assessment of sustainability - e.g., one-off gains, asset sales, or cost deferrals.
• Liquidity and dividend policy risk: Continuing dividends (last paid Aug 2025) create tension between shareholder returns and the need to preserve cash to address Shanshan's short-term funding gaps.
• Shareholder influence: Gortune Investment's 16.02% stake may accelerate strategic decisions but also concentrate downside if its interests diverge from minority shareholders.

China Baoan Group Co., Ltd. (000009.SZ) - Growth Opportunities

• Allocated 500 million CNY for green technology and renewable energy projects to reduce operational carbon intensity and open new revenue streams.
• Ambition to grow international sales to 30% of total revenue by 2025; international sales reached 3.0 billion CNY in 2023, signaling a sizable runway for overseas expansion.
• Planned investment of ~200 million CNY in employee training programs in 2024 to upgrade workforce capabilities and support scale-up in new markets.
• Retention and culture targets: raise employee retention to 85% by 2025 and improve job-satisfaction metrics through training, career-pathing, and benefits.
• Maintains a shareholder-friendly posture with a history of dividend distributions; most recent dividend paid in August 2025.

• Strategic implications: green-investment spend can lower future regulatory and carbon costs while enabling product/service differentiation; training spend supports international scaling and productivity improvements.
• Execution risks: achieving 30% international share depends on market entry strategy, channel partnerships, FX exposure, and local regulatory compliance.
• Investor watchpoints: quarterly trends in international revenue, ROI on green projects, training-to-productivity metrics, retention rate progression toward 85%, and dividend policy updates.